Curriculum Vitae Clay J. Cockerell, M.D. Home

Total Page:16

File Type:pdf, Size:1020Kb

Curriculum Vitae Clay J. Cockerell, M.D. Home CURRICULUM VITAE CLAY J. COCKERELL, M.D. HOME ADDRESS 4312 Arcady Avenue Dallas, Texas 75205 (214) 522-2610 WORK ADDRESS Cockerell & Associates-Dermpath Diagnostics Dermatopathology Laboratories 2330 Butler Street, Suite 115 Dallas, Texas 75235 Phone: (214) 530-5200, (800) 309-0000 Fax: (214) 530-5232 BIRTH DATE AND PLACE September 16, 1956, Houston, Texas MARITAL STATUS Married - Brenda West Cockerell Two children - Charles West Cockerell & Lillian Allene Cockerell COLLEGE EDUCATION 1974 – 1977 Texas Tech University Majors: Zoology, Microbiology, Chemistry No degree - entered Medical School via Early Decision Program GRADUATE EDUCATION 1977 - 1981 Baylor College of Medicine Degree - M.D. with honors, June 1981 POSTGRADUATE EDUCATION 1981-1982 Internship, Internal Medicine University of Washington Affiliated Hospitals, Seattle, Washington 1982-1985 Residency, Dermatology New York University Medical Center, New York, New York 1984-1985 Chief Resident, Dermatology New York University Medical Center, New York, New York 1985-1986 Fellowship, Dermatopathology New York University Medical Center, New York, New York OTHER TRAINING Sloan-Kettering Memorial Hospital, Pathology New York, New York Part-time clinical observer July 1986 - January 1987 Clay J. Cockerell, M.D. Updated 1/15/2018 Page 2 ACADEMIC APPOINTMENTS University of Texas Southwestern Medical Center Assistant Professor, Dermatology and Pathology, September 1988 - September 1992 Associate Professor, Dermatology and Pathology, September 1992 - September 1993 Clinical Associate Professor, Dermatology and Pathology September 1993 - June 1997 Clinical Professor, Dermatology and Pathology, June 1997 - present Associate in Dermatopathology, September 1988 - January 1992 Director, Division of Dermatopathology, February 1, 1992 - Present Director, HIV-Related Skin Disease Clinic Parkland Hospital, April 1990 – June 2000 (clinic discontinued) New York University Medical Center Teaching Assistant, Dermatology, June 1985 - June 1986 Associate in Dermatopathology, June 1986 - September 1988 Assistant Professor, Dermatology, June 1986 - September 1988 SELECTED PROFESSIONAL Baylor Medical Center Grapevine HOSPITAL APPOINTMENTS Baylor University Medical Center Children’s Medical Center Denton Community Hospital Hendrick Medical Center (Abilene, TX) Medical Center of Mesquite Medical City Dallas Parkland Memorial Hospital Presbyterian Hospital of Dallas Presbyterian Hospital of Plano Trinity Mother Frances (Tyler, TX) Zale Lipshy University Hospital St. Paul Medical Center MEDICAL PRACTICE Medical Director, Cockerell & Associates/Dermpath Diagnostics Dermatopathology Laboratories Owner, Cockerell Dermatopathology Consultation Services, P.A. LICENSURE Federal Licensure Examination (FLEX), 1981 Special Purpose Examination (SPEX), 1996 American Board of Dermatology, 1985, recertified 1997, 2008 American Boards of Dermatology and Pathology (Dermatopathology), 1986, recertified 1997, 2008 Arkansas State Board of Medical Examiners, 1998, No. E-1696 Arizona State Board of Medical Examiners, 1997, No. 25085 California State Board of Medical Examiners, 1997, No. C50087 Colorado State Board of Medical Examiners, 1999, No. 36683 Florida State Board of Medical Examiners, 1997, No. ME-69877 Clay J. Cockerell, M.D. Updated 1/15/2018 Page 3 Georgia State Board of Medical Examiners, 1998, No. 44902 Idaho State Board of Medicine 2009, M-10660 Illinois State Board of Medical Examiners, 2008, No.36.120172 Iowa State Board of Medical Examiners, 2007, No. 37353 Kansas State Board of Medical Examiners, 1996, No. 426364 Kentucky State Board of Medical Examiners, 2006, No. 40131 Louisiana State Board of Medical Examiners, 1998, No. 12554R Minnesota Board of Medical Practice 2010, No. 1436 Missouri State Board of Medical Examiners, 1998, No. 114299 Nebraska Department of Health 2009, No. 25153 New Jersey State Board of Medical Examiners, 1985, No. MA45832 New Mexico State Board of Medical Examiners, 1997, No. 97210 New York State Board of Medical Examiners, 1983, No. 154990 1 North Carolina State Board of Medical Examiners, 1997, No. 9701726 Ohio State Board of Medical Examiners, 1997, No. 35-07-2885-C Oklahoma State Board of Medical Examiners, 1997, No. 20498 South Carolina State Board of Medical Examiners, 1997, No. 19310 Tennessee State Board of Medical Examiners, 2008, No. MD0000043200 Texas State Board of Medical Examiners, 1981, No. F9311 Utah State Board of Medical Examiners, 2007, No. 6581738-1205 Virginia State Board of Medical Examiners, 1999, No. 101059075 PROFESSIONAL American Academy of Dermatology, Fellow SOCIETIES American Academy of HIV Medicine American College of Osteopathic Family Physicians American College of Physician Executives American Contact Dermatitis Society American Dermatological Association American Medical Association American Society of Clinical Pathologists American Society for Dermatologic Surgery American Society of Dermatology American Society of Dermatopathology California Society of Dermatology and Dermatologic Surgery College of American Pathologists Dallas County Medical Society Dallas Dermatological Society Dermatology Foundation International Academy of Pathology International AIDS Society International Society of Dermatology Leaders Society Dermatology Foundation Louisiana Dermatologic Society Masters Dermatologic Association Noah Worcester Dermatological Society North American Clinical Dermatologic Society Pacific Dermatological Association Physicians Association for AIDS Care Clay J. Cockerell, M.D. Updated 1/15/2018 Page 4 Richard L. Sutton Dermatological Society Sir James Saunders Society Society for Investigative Dermatology South Central Dermatology Society Southern Medical Association Southwestern Dermatology Association Texas Dermatological Society Texas Medical Association Texas Society of Pathologists United States and Canadian Academy of Pathology Women’s Dermatologic Society COMMITTEES & BOARDS International Society of Dermatopathology Executive Committee, 1986 - 2000 Membership Committee (Chairman), 1990 - 1996 Regional Programs Committee (Chairman), 1996 - 2000 American Academy of Dermatology Board of Directors 1997 - 2003 Committee on HIV-Related Disorders 1989 - 1993 Chairman 1994 - 1999 Committee on Melanoma and Skin Cancer Prevention, 1992 - 1997 Epidemiology Committee, 1994 - 1998 Operations Committee, 1994 - 1998 Melanoma Self-Examination Task Force, 1995 - 1997 Chairman, 1995 - 1997 Dermatopathology Liaison Committee, 1995 - 1999 Chairman, 1995 - 1999 Guidelines for HIV Diseases, 1995 - 1997 HIV Disease Task Force (Chairman), 1999 Intersociety Liaison Committee, 1999 Futures Committee, 1995 - 1999 Audit Committee, 1997 - 2003 Advisory Board District 6 Representative, 1996 - 1998 Executive Committee, 1996-1998 Executive Committee, 1997 - 2003 Priorities Committee, 1997 - 2003 Dermatology Services, Inc. Board of Directors, 1999 - 2003 Investments Committee, 1997 - 2003 Member Services Committee, 1999 - 2003 Scientific Assembly Council, 1997 – 2003 SKIN PAC Committee, 2005-Present Past Presidents, Advisory Committee, 2005-Present (Lifetime appointment) American Cancer Society Committee on Skin Cancer Prevention, 1990 - 1997 Clay J. Cockerell, M.D. Updated 1/15/2018 Page 5 University of Texas Southwestern Medical Center Continuing Education Advisory Committee, 1989 - 1993 Committee on Biologic and Chemical Safety, 1991 - 1993 Faculty Senate Representative, Dept. of Dermatology, 1991 – 1993 Physicians Association for AIDS Care Trustee, 1989 - 1994 Chairman, Ethics Committee, 1990 - 1991 Chairman, PAAC Notes Committee, 1990 – 1992 Southern Medical Association Advisory Committee on Publications and Advertising, 1992 - 2000 American Society of Dermatopathology Peer Review Committee, 1991 – 1995, Chairman, 1995 Managed Care & Political Issues Committee, 1995 - 2000 American Contact Dermatitis Society Liaison Officer, 1992 – 1993 Texas Dermatological Society Program Chairman & Coordinator, Spring Meeting, May 19-21, 1995 Advisory Board Delegate-American Academy of Dermatology, 1995 – 1997; Trustee, 2001-2006 President, April 2003 – April 2004 DermPac (Dermatology Political Action Committee) Organizing Committee, 1994 – 1996 American Board of Dermatology Test Committee, 1997 – 2003 Dallas Dermatologic Society Socioeconomic Committee Chairman, 1997 – 2001 American Dermatological Association, Inc. Program Committee, 2004 – 2005 Golf Committee, 2005 - present Galderma – Executive Advisory Board, 2005 - 2007 PTV Sciences, L.P. – Scientific Advisory Board, 2004 – present Intraop Medical – Scientific Advisory Board, 2007-present Sensus Health Care—Scientific Advisory Board, 2011-present Clay J. Cockerell, M.D. Updated 1/15/2018 Page 6 National Society of Cutaneous Medicine – Board of Directors, January 2011 to Present Noah Worester Dermatological Society – Board of Trustees, February 2009 to Present Assistant Secretary Treasurer, 2011; Secretary Treasurer 2012-2016 Zola Cooper Clinico-Pathologic Seminar—Board of Directors and Seminar Director, 1993-present ACTIVITIES, AWARDS, American Academy of Dermatology OFFICES Past President, American Academy of Dermatology, 2006 President, American Academy of Dermatology, 2005 President-Elect, American Academy of Dermatology, 2004 Secretary/Treasurer, American Academy of Dermatology, 2001 – 2004 Assistant Secretary/Treasurer, American Academy of Dermatology, 1998 – 2001 AmeriPath, Inc. Medical Director, Division of Dermpath Diagnostics 2000 – Present Board of Directors, 2004 - 2007 Other Honorary Member, Dallas Dermatological
Recommended publications
  • Pathogenesis of Rosacea Anetta E
    REVIEW Pathogenesis of Rosacea Anetta E. Reszko, MD, PhD; Richard D. Granstein, MD Rosacea is a chronic, common skin disorder whose pathogenesis is incompletely understood. An inter- play of multiple factors, including genetic predisposition and environmental, neurogenic, and microbial factors, may be involved in the disease process. Rosacea subtypes, identified in the recently published standard classification system by the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea, may in fact represent different disease processes, and identifying subtypes may allow investigators to pursue more precisely focused studies. New developments in molecular biology and genetics hold promise for elucidating the interplay of the multiple factors involved in the pathogen- esis of rosacea, as well as providing the bases for potential new therapies. osacea is a common, chronic skin disorder and secondary features needed for the clinical diagnosis primarily affecting the central and con- of rosacea. Primary features include flushing (transient vex areas of COSthe face. The nose, cheeks, DERM erythema), persistent erythema, papules and pustules, chin, forehead, and glabella are the most and telangiectasias. Secondary features include burn- frequently affected sites. Less commonly ing and stinging, skin dryness, plaque formation, dry affectedR sites include the infraorbital, submental, and ret- appearance, edema, ocular symptoms, extrafacial mani- roauricular areas, the V-shaped area of the chest, and the festations, and phymatous changes. One or more of the neck, the back, and theDo scalp. Notprimary Copy features is needed for diagnosis.1 The disease has a variety of clinical manifestations, Several authors have theorized that rosacea progresses including flushing, persistent erythema, telangiecta- from one stage to another.2-4 However, recent data, sias, papules, pustules, and tissue and sebaceous gland including data on therapeutic modalities of various sub- hyperplasia.
    [Show full text]
  • (2006.01) Published: A61K9/08
    ) ( (51) International Patent Classification: Published: A61K 31/05 (2006.01) A61P 1 7/02 (2006.01) — with international search report (Art. 21(3)) A61K9/08 (2006.01) A61P29/00 (2006.01) A61P 1 7/00 (2006.01) (21) International Application Number: PCT/AU20 19/05005 1 (22) International Filing Date: 24 January 2019 (24.01.2019) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 2018900226 24 January 2018 (24.01.2018) AU 62/621,225 24 January 2018 (24.01.2018) US 2018903600 25 September 2018 (25.09.2018) AU 62/736,052 25 September 2018 (25.09.2018) US (71) Applicant: BOTANIX PHARMACEUTICALS LTD [AU/AU]; 63 Aberdeen Street, Northbridge, Western Aus¬ tralia 6003 (AU). (72) Inventors: CALLAHAN, Matthew; One Kew Place, 150 Rouse Boulevard, Navy Yard Corporate Center, Philadel¬ phia, Pennsylvania 191 12 (US). THURN, Michael; 912 Kangaroobie Road, Kangaroobie, NSW 2800 (AU). (74) Agent: WRAYS PTY LTD; Level 7, 863 Hay Street, Perth, Western Australia 6000 (AU). (81) Designated States (unless otherwise indicated, for every kind of national protection available) : AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • A Dissertation on CLINICO EPIDEMIOLOGICAL STUDY of FACIAL DERMATOSES AMONG ADULTS
    A Dissertation on CLINICO EPIDEMIOLOGICAL STUDY OF FACIAL DERMATOSES AMONG ADULTS Dissertation submitted to THE TAMILNADU DR.M.G.R. MEDICAL UNIVERSITY CHENNAI-600032 With partial fulfillment of the requirements for the award of M.D.DEGREE IN DERMATOLOGY, VENEREOLOGY AND LEPROLOGY (BRANCH - XX) REG. No. 201730201 COIMBATORE MEDICAL COLLEGE AND HOSPITAL COIMBATORE MAY 2020 DECLARATION I Dr . MANIVANNAN . M solemnly declare that the dissertation entitled “CLINICO EPIDEMIOLOGICAL STUDY OF FACIAL DERMATOSES AMONG ADULTS ” is a bonafide work done by me at Coimbatore Medical College Hospital during the year June 2018 to May 2019 under the guidance & supervision of Dr. M. KARUNAKARAN M.D., (DERM) Professor& Head of Department, Department of Dermatology, Coimbatore Medical College & Hospital. The dissertation is submitted to Dr. MGR Medical University towards partial fulfillment of requirement for the award of MD degree branch XX Dermatology, Venereology and Leprology. PLACE: Dr. MANIVANNAN .M DATE: CERTIFICATE This is to certify that the dissertation entitled “CLINICO EPIDEMIOLOGICAL STUDY OF FACIAL DERMATOSES AMONG ADULTS” is a bonafide original work done by Dr. MANIVANNAN.M. Post graduate student in the Department of Dermatology, Venereology and Leprology, Coimbatore Medical College Hospital, Coimbatore under the guidance of Dr. M. KARUNAKARAN M.D., (DERM), Professor and HOD of Department, Department of Dermatology, Coimbatore Medical College Hospital, Coimbatore in partial fulfillment of the regulations for the Tamilnadu DR.M.G.R Medical University, Chennai towards the award of MD., degree (Branch XX.) in Dermatology, Venereology and Leprology. Date : GUIDE Dr. M. KARUNAKARAN M.D., (DERM) Professor & HOD, Department of Dermatology, Coimbatore Medical College & Hospital. Date : Dr.
    [Show full text]
  • Dermatology 101: from Acne to Zebras and the Pearls in Between
    Dermatology 101: From Acne to Zebras and the Pearls in Between Dr Kyle Cullingham, BA, BSc, MSc, MD, FRCPC Dermatologist Skinsense Dermatology, Saskatoon,SK Assistant Professor University of Saskatchewan Disclosures Speaker: Dr Kyle Cullingham Relationships with commercial interests: Speakers Bureau/Honoraria: Abbvie, Allergan, Celgene, LEO Consulting Fees: Abbvie, Celgene, Galderma, Janssen, LEO, Novartis Conflict of Interest Declaration: Nothing to Disclose Presenter: Dr. Kyle Cullingham Title of Presentation:Dermatology for GPs I have no financial or personal relationship related to this presentation to disclose. Objectives Discuss some common dermatological concerns – focus on recognition, management, what’s new and pearls. Acne Clinical pearls Rosacea Psoriasis Eczema Interspersed with interesting real Dermatology cases with common pitfalls, red flags, or learning points. Time for questions/comments Acne disorder of the pilosebaceous unit affects certain areas of the body: face > trunk >> buttocks manifests during adolescence, but can occur at any stage of life comedones, papulopustules, nodules, cysts scarring can follow Epidemiology acne affects approximately 85% of adolescents onset during puberty (10-19 y/o); may appear after age 25 more severe in men higher incidence in caucasians and indigenous population inheritance: multifactorial; most patients with cystic acne have parental history of severe acne Pathogenesis Corneocyte Sebum Propionibacterium acnes Inflammatory cell Drugs Diet Recent JAAD review
    [Show full text]
  • Kazlouskaya V
    MINISTRY OF HEALTH OF REPUBLIC OF BELARUS GOMEL STATE MEDICAL UNIVERSITY V. V. Kazlouskaya SELECTED LECTURES ON DERMATOLOGY Manual for foreign medical students Gomel GSMU 2008 УДК 616.5 (075.8)=20 ББК 55.8 К 59 Рецензеты: заведующий кафедрой дерматовенерологии УО «Витебский государственный медицинский университет», доктор медицинских наук, профессор В. П. Адаскевич; заведующий кафедрой поликлинической терапии и общеврачебной практики с курсом дерматовенерологии УО «Гомельский государственный медицинский университет», кандидат медицинских наук, доцент Э. Н. Платошкин. Козловская, В. В. К 59 Курс лекций по дерматологии: учеб.-метод. пособие для студентов- медиков = Selected Lectures on Dermatology: manual for foreign medical students / В. В. Козловская. — Гомель: Учреждение образования «Го- мельский государственный медицинский университет», 2008. — 160 с. ISBN 978-985-506-210-4 Учебно-методическое пособие «Selected Lectures on Dermatology» представляет собой курс лекций по дерматологии, предназначенный для иностранных студентов 3 курса, обучающихся на английском языке. Лекции составлены в соответствии с типовой учебной программой и содержат основные разделы цикла дерматология. Утверждено и рекомендовано к изданию Центральным учебным научно- методическим советом учреждения образования «Гомельский государственный медицинский университет» 20 ноября 2008 г., протокол № 11. УДК 616.5 (075.8) ББК 55.8 ISBN 978-985-506-210-4 © Учреждение образования «Гомельский государственный медицинский университет», 2008 2 Abbreviations Used in the Book AA
    [Show full text]
  • UC Davis Dermatology Online Journal
    UC Davis Dermatology Online Journal Title Otophyma: a rare benign clinical entity mimicking leprosy Permalink https://escholarship.org/uc/item/41p4q5xq Journal Dermatology Online Journal, 21(3) Authors Shuster, Marina McWilliams, Ashley Giambrone, Danielle et al. Publication Date 2015 DOI 10.5070/D3213024280 Supplemental Material https://escholarship.org/uc/item/41p4q5xq#supplemental License https://creativecommons.org/licenses/by-nc-nd/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Volume 21 Number March 2015 Photo vignette Otophyma: a rare benign clinical entity mimicking leprosy Marina Shuster BA1, Ashley McWilliams BS2, Danielle Giambrone BS3, Omar Noor MD3, Jisun Cha MD3 Dermatology Online Journal 21 (3): 22 1Harvard Medical School 2Virginia Commonwealth University School of Medicine 3Rutgers- Robert Wood Johnson Medical School Correspondence: Danielle Giambrone Department of Dermatology Rutgers- Robert Wood Johnson Medical School 1 World’s Fair Drive Somerset, NJ 08873 Email: [email protected] Phone: 609-220-7710 Abstract Otophyma is a rare condition characterized by edematous deformation of the ear that is considered to be the end-stage of an inflammatory process such as rosacea and eczema. This report illustrates a case in an elderly male, originally thought to have leprosy. Biopsy revealed a nodular infiltration of inflammatory cells around adnexal structures and an intraepidermal cyst. No acid-fast organisms were identified. We present a patient who is of a different ethnic group than usually seen with this disease and provide a review of the clinical presentation, histopathological features, and management of this rare condition. Keywords: Otophyma, Leprosy, Rhinophyma, Rosacea Case synopsis A 62-year-old Filipino male presented for evaluation of his grossly enlarged ears.
    [Show full text]
  • Internal Medicine In-Review Study Guide
    INTERNAL MEDICINE IN-REVIEW STUDY GUIDE Companion to the Online Study System InReviewIM.com Senior Editor Norman H. Ertel, MD Associate Editors James M. Horowitz, MD Miguel A. Paniagua, MD, FACP Available through support from the makers of Powered by © 2013 Educational Testing & Assessment Systems. All Rights Reserved. This document contains proprietary information, images, and marks of Educational Testing & Assessment Systems. No reproduction or use of any portion of the contents of these materials may be made without the express written consent of Educational Testing & Assessment Systems. If you feel you have obtained this illegally, please contact Educational Testing & Assessment Systems immediately. The questions and answers, statements or opinions contained in this Study Guide or Web Site have not been approved by McNeil Consumer Healthcare Division of McNEIL-PPC, Inc., the makers of TYLENOL®. McNeil will not be held responsible for any questions and answers, statements or opinions, contained in the Study Guide, Web Site, or any supplementary materials. Any questions about the content of Internal Medicine In-Review should be directed to Educational Testing and Assessment Systems, Inc. which controls the content and owns all copyrights in the materials. The developments in medicine are always changing, from clinical experiences, new research, and changes in treatment and drug therapy. The Internal Medicine In-Review team use reasonable efforts to include information that is complete and within accepted standards at the time of publication. However, the faculty, authors, publisher, nor any other party who has been involved in the preparation of Internal Medicine In-Review make representations, warranties, or assurances as to the accuracy, currency, or completeness of the information provided.
    [Show full text]
  • Triggers and Treatment of Rosacea
    MedicineToday 2015; 16(1): 34-40 PEER REVIEWED FEATURE 2 CPD POINTS Triggers and treatment of rosacea SHIEN-NING CHEE MB BS, MMed PATRICIA LOWE MB BS, MMed, FACD Key points Rosacea is a common chronic inflammatory skin condition that can • Rosacea is a common lead to significant facial changes, ocular involvement and decreased condition characterised by quality of life. Its cause is multifactorial and not completely understood. flushing, erythema, inflammatory lesions and Treatment aims to control, but not cure, the disease. telangiectasia. • The cause is multifactorial osacea is a common chronic inflam­ PATHOPHYSIOLOGY and not completely matory skin disease primarily affecting The pathophysiology of rosacea is multifactorial understood: genetics, the facial convexities. It is characterised and not completely understood. At present, neurovascular dysregulation Rby vascular lability, leading to flushing, rosacea is thought of as a complex inflammatory and infections may be telangiectasia and fixed erythema, and cuta­ disorder arising in genetically predisposed involved. neous inflammation, manifesting as papules, individuals. • Diagnosis of rosacea is pustules and lymphoedema. Although not based on clinical findings, life ­threatening, rosacea may have a significant Genetics although investigations may impact on a patient’s self­esteem and quality of Rosacea often affects multiple family members. be required to exclude life. Early diagnosis and treatment will reduce Recent analyses have found distinct genetic differential diagnoses. morbidity. profiles for each rosacea subtype, with expres­ • Treatment is tailored to the sion of more than 500 different genes compared individual and aims to EPIDEMIOLOGY with healthy skin.3 The skin of patients with control symptoms and signs, Estimated prevalence rates of rosacea range from rosacea has been found to be dry and acidic, but not cure the disease.
    [Show full text]
  • Acne and Acneiform Related Eruptions
    Acne and acneiform related eruptions Objectives : ➢ To know the multiple pathogenetic mechanisms causing acne ➢ To recognize the clinical features of acne. ➢ To differentiate acne from other acneiform eruptions such as rosacea. ➢ To prevent acne scars and treat acne efficiently. ➢ To recognize the clinical features of rosacea, it’s variable types, differential diagnosis and treatment ➢ To recognize the features of perioral dermatitis, differential diagnosis and treatment. ➢ To recognize the features of hidradenitis suppurativa and treatment Done by: Sadeem Alqahtani & Khawla Alammari Revised by: Lina Alshehri. [ Color index : Important | Notes | Extra ] ​ ​ ​ ​ ​ ​ ​ ACNE VULGARIS Definition/prevalence: ● Multifactorial disease of pilosebaceous unit that affects both males and females. ​ ​ ● It is the most common dermatological disease. ● Mostly prevalent between 12-24 yrs. Affects 8% between 25-34, 4% between 35-44. Pathogenesis: 1- Ductal cornification and occlusion (micro-comedo). 2- Increased sebum secretion (Seborrhoea). 3- Ductal colonization with propionibacterium acnes. 4- Rupture of sebaceous gland and inflammation. Specialized terms: ● Microcomedone: Hyperkeratotic plug made of sebum and keratin in follicular canal. ​ ● Closed Comedo (Whitehead): Closed follicular orifice, accumulation of sebum and keratin ​ ​ ​ ​ ● Open Comedo (Blackhead): Opened follicular orifice packed with melanin and oxidized lipids ​ ​ ​ ​ ● We categorize acne (depending on the type of lesion) into: mild, moderate and severe. Comedones are considered mild. Nodules, cysts, pustules (can lead to scarring or hyperpigmentation) are ​ ​ considered moderate to severe. ​ ​ ● Our pathognomonic lesion is comedone, you can NOT diagnose acne without having comedones, if you do not have comedones THIS IS NOT ACNE! Clinical features: Acne lesions are divided into: ● Inflammatory (papules,pustules,nodules,cyst). ● Non inflammatory (open, closed comedones).
    [Show full text]
  • Rhinophyma: Practical and Safe Treatment with Trichloroacetic Acid
    RevSurgicalV6N4-ingles_RevistaSurgical&CosmeticDermatol 26/03/15 08:49 Page 368 368 New Techniques Rhinophyma: practical and safe treatment with trichloroacetic acid Rinofima: tratamento prático e seguro com ácido triclcoroacético Author Neide Kalil Gaspar1 Antonio Pedro Andrade Gaspar2 Marcia Kalil Aidê3 1 Dermatologist Physician; Emeritus Professor at the Universidade Federal Fluminense (UFF) – Niterói (RJ), Brazil 2 Dermatologist Physician; Assistant ABSTRACT Professor, UFF The authors introduce a method for the treatment of different intensities and scales of rhi- nophyma, with trichloroacetic acid. This is a safe process, created and performed by the 3 Dermatologist Physician at private practice - Niterói (RJ), Brazil authors for five decades, with an absence of descriptions of adverse effects. Keywords: trichloroacetic acid; rhinophyma; therapeutics. RESU MO Apresentamos método de tratamento com ácido tricloroacético para casos de rinofima de diferentes intensidades e extensões. Trata-se de processo seguro, que criamos há cinco décadas e desde então vimos executando, sem nenhum efeito adverso. Palavras-chave: ácido tricloroacético; rinofima; terapêutica. INTRODUCTION Rhinophyma is a disfiguring and progressive disorder of the nasal skin, characterized by hyperplasia of the sebaceous glands with occlusion of the ducts and dermal fibrosis, typically affecting middle aged Caucasian men. This process occurs most commonly in rosacea patients Correspondence: and can affect the frontal region (metophyma) or, more rarely, Neide Kalil Gaspar R. Erotides de Oliveira, 36/301 – Icarai the ears (otophyma), eyelids (blepharophyma), or the mentum Cep: 24230-230 - Niterói (RJ), Brazil (gnatophyma). E-mail: [email protected] Its development is progressive and deforming, and in some patients there can be intermittent inflammation, which may result in scars and fibrous tissue.
    [Show full text]
  • The Effect of Probiotics on Skin
    December 2014 The effect of probiotics on skin Probiotics in dermatology — from theory to enterprise ACADEMIC CONSULTANCY TRAINING Group 1457 Bob van den Berg Jiang Chang Aafke Duizendstra Renate Jansen Ana Jimena Pacheco Gutierrez Tian Zhao Coach: Carel Weijers Content coach: Willemien Lommen Commissioner: Skinwiser, Dr Jetske Ultee & Matthijs Boog Ana Jimena Pacheco Gutierrez [email protected] 0626667543 Stichting Skinwiser Matthijs Boog ([email protected]) Maasstraat 11 3016 DB Rotterdam Source image: “ The trillions of microbes in and on our bodies are key to understanding our health ” Follow Up on AO+ Living Bacterial Skin Tonic - Allergies & Your Gut (Accessed December 5, 2014) Disclaimer This report (product) is produced by students of Wageningen University as part of their MSc- programme. It is not an official publication of Wageningen University or Wageningen UR and the content herein does not represent any formal position or representation by Wageningen University. Part of MSc course Academic Consultancy Training (9 ECTS) Copyright © 2014 All rights reserved. No part of this publication can be reproduced or distributed in any form or by any means, without the prior consent of the authors. i The effect of probiotics on skin ACT group 1457 Team logo of ACT group 1457, all rights reserved “ Staphylococcus epidermidis protects our skin from the invading pathogens ” ii Executive summary This project was commissioned by Skinwiser to examine whether probiotics can have a positive effect on the skin. We assessed if topical application of probiotics can improve healthy or affected skin. The skin conditions included are rosacea, acne and atopic dermatitis. First, literature about healthy skin, skin conditions and (gut) probiotics was studied.
    [Show full text]
  • Abstract Case Synopsis
    Volume 21 Number March 2015 Photo vignette Otophyma: a rare benign clinical entity mimicking leprosy Marina Shuster BA1, Ashley McWilliams BS2, Danielle Giambrone BS3, Omar Noor MD3, Jisun Cha MD3 Dermatology Online Journal 21 (3): 22 1Harvard Medical School 2Virginia Commonwealth University School of Medicine 3Rutgers- Robert Wood Johnson Medical School Correspondence: Danielle Giambrone Department of Dermatology Rutgers- Robert Wood Johnson Medical School 1 World’s Fair Drive Somerset, NJ 08873 Email: [email protected] Phone: 609-220-7710 Abstract Otophyma is a rare condition characterized by edematous deformation of the ear that is considered to be the end-stage of an inflammatory process such as rosacea and eczema. This report illustrates a case in an elderly male, originally thought to have leprosy. Biopsy revealed a nodular infiltration of inflammatory cells around adnexal structures and an intraepidermal cyst. No acid-fast organisms were identified. We present a patient who is of a different ethnic group than usually seen with this disease and provide a review of the clinical presentation, histopathological features, and management of this rare condition. Keywords: Otophyma, Leprosy, Rhinophyma, Rosacea Case synopsis A 62-year-old Filipino male presented for evaluation of his grossly enlarged ears. He had a 30-year-history of ear swelling which had recently become very itchy. He has never had his ear evaluated or treated over the past 30 years but most recently started hydrocortisone cream with no relief of his itching. Physical examination was notable for significant bilateral auricular enlargement with scattered pustules (Figure 1). No paraesthesia was noted. A punch biopsy was performed and sent for histologic analysis and culture.
    [Show full text]